577 related articles for article (PubMed ID: 23399425)
1. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
3. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
[TBL] [Abstract][Full Text] [Related]
4. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
6. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
Kissling E; Rondy M;
Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524
[TBL] [Abstract][Full Text] [Related]
7. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.
Kissling E; Valenciano M;
Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435329
[TBL] [Abstract][Full Text] [Related]
8. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.
Valenciano M; Kissling E; Cohen JM; Oroszi B; Barret AS; Rizzo C; Nunes B; Pitigoi D; Larrauri Cámara A; Mosnier A; Horvath JK; O'Donnell J; Bella A; Guiomar R; Lupulescu E; Savulescu C; Ciancio BC; Kramarz P; Moren A
PLoS Med; 2011 Jan; 8(1):e1000388. PubMed ID: 21379316
[TBL] [Abstract][Full Text] [Related]
9. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
[TBL] [Abstract][Full Text] [Related]
10. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
[TBL] [Abstract][Full Text] [Related]
11. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
Jiménez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Pérez E; Gallardo V; Rodriguez C; Vega T; Quiñones C; Martínez E; Vanrell JM; Giménez J; Castrillejo D; Serrano Mdel C; Ramos JM; Larrauri A;
BMC Infect Dis; 2013 Sep; 13():441. PubMed ID: 24053661
[TBL] [Abstract][Full Text] [Related]
13. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
Kissling E; Valenciano M;
Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009].
Piţigoi D; Lupulescu E; Alexandrescu V; Băeţel A; Sbârcea C; Ioniţă E; Săvulescu C; Duca E; Sima C; Truică C; Ibram S; Bobîrnac A; Militaru L; Arion M
Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):109-16. PubMed ID: 20422925
[TBL] [Abstract][Full Text] [Related]
15. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
Valenciano M; Kissling E;
Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
[TBL] [Abstract][Full Text] [Related]
16. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.
Kissling E; Valenciano M; Cohen JM; Oroszi B; Barret AS; Rizzo C; Stefanoff P; Nunes B; Pitigoi D; Larrauri A; Daviaud I; Horvath JK; O'Donnell J; Seyler T; Paradowska-Stankiewicz IA; Pechirra P; Ivanciuc AE; Jiménez-Jorge S; Savulescu C; Ciancio BC; Moren A
PLoS One; 2011; 6(11):e27622. PubMed ID: 22110695
[TBL] [Abstract][Full Text] [Related]
17. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A
Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000
[TBL] [Abstract][Full Text] [Related]
18. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
[TBL] [Abstract][Full Text] [Related]
19. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
Rondy M; Puig-Barbera J; Launay O; Duval X; Castilla J; Guevara M; Costanzo S; de Gaetano Donati K; Moren A
PLoS One; 2013; 8(4):e59681. PubMed ID: 23565159
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
